Merck wins FDA approval for 56% LDL cut
Merck (NYSE:MRK) received FDA approval for Lipfendra 20 mg after a Phase 3 trial showed a 56% LDL-C reduction versus placebo.
Merck (NYSE:MRK) received FDA approval for Lipfendra 20 mg after a Phase 3 trial showed a 56% LDL-C reduction versus placebo.
U.S. Bancorp (NYSE:USB) reported Q1 2026 net revenue of $7.288 billion and diluted EPS of $1.18, exceeding the $1.14 analyst estimate.
Eli Lilly (NYSE:LLY) executed a definitive agreement to acquire AtaiBeckley (NASDAQ:ATAI) for a $2.8 billion upfront equity valuation.
Tether, the world's largest stablecoin issuer by market capitalisation, has invested US$20 million in Argentine digital bank Ualá as part of a broader push to expand its presence across South America.
AtaiBeckley (NASDAQ:ATAI) shares jumped about 50% after Bloomberg reported that Eli Lilly (NYSE:LLY) could acquire the psychedelic drug developer this week.
Insteel (NYSE:IIIN) reported $197.7 million in net sales and $9 million in net earnings for the third quarter of fiscal 2026.
On-chain analyst PlanB, creator of the Stock-to-Flow model, has revised his Bitcoin (CRYPTO:BTC) price projection for the current halving cycle to a range of US$250,000 to US$1 million, with an average target of approximately US$500,000 before the cycle concludes.
Citizens Financial Group (NYSE:CFG) reported a second-quarter net income of $587 million and earnings of $1.30 per share.
Dorian LPG (NYSE:LPG) declared a $1.00 per share irregular cash dividend to return $42.8 million to shareholders.
Immuron (NASDAQ:IMRN) reported unaudited FY26 global Travelan sales of AUD$7.7 million, representing year-over-year growth of 6%.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy